Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
3.730
+0.070 (1.91%)
At close: Nov 6, 2026, 4:00 PM EST
3.688
-0.042 (-1.13%)
After-hours: Nov 6, 2026, 7:30 PM EST
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $15.1 million as of November 6, 2026. It is the 38,672nd most valuable company in the world and the 5,326th biggest in the United States. Its market cap has decreased by 66.06% in one year.
Market Cap
15.10M
Enterprise Value
-76.21M
1-Year Change
-66.06%
Global Rank
Country Rank
#5,326 United States
Category
ChartMarket Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $15.10M, a decrease of -98.77%. That is a compound annual growth rate of -30.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 15.10M | -57.46% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 16.91M |
| Akari Therapeutics, | 16.84M |
| Estrella Immunopharma | 16.32M |
| Acumen Pharmaceuticals | 16.17M |
| NewcelX | 15.74M |
| aTyr Pharma | 15.57M |
| Allarity Therapeutics | 15.35M |
| Pluri | 15.25M |